Ask your doctor about ImmunoFormulation (IF): A combination of nutraceuticals that can help COVID19 patients

The immune system is our defensive mechanism of the body that helps in fighting infection. Protecting your immune system with the administration of ImmunoFormulation (IF) can help you keep coronavirus at bay as per the evidence-based study.

COVID19 is caused by the acute respiratory distress syndrome coronavirus has being spread worldwide for more than a year. Although vast knowledge has been gathered about coronavirus, limited options are available for its treatment. We all understand with this coronavirus outbreak that “Prevention is better than cure”. In this context, agents that can act as prophylactics and adjuvants to the therapies are of high value. This includes a good amount of vitamin supplements and nutraceuticals that can help boost your immunity. 

Coronavirus affects and lowers the immune system

Weakened immunity can result in being more prone to infections like COVID19. When it comes to pathological findings, it is now clear that coronavirus involves the affection of the immune system with inflammatory effects. Preventing the coronavirus at an early stage can help you a lot. Taking vitamin supplements and nutraceuticals can help your body prevent the attack of coronavirus. Not to forget, the guidelines of social distancing, sanitizing, and wearing a mask are equally important. 

An observational study with  ImmunoFormulation (IF) treatment in SARS-Co-V-2 positive patients.

A study was carried out to describe the course of the disease SARS-Co-V2 on patients treated with ImmunoFormulation (IF). 

There were two groups of patients analyzed which are as follows:  

1)A group of patients who received ImmunoFormulation (IF) during the course of SARS-CoV-2

2) )A group of patients who did not receive ImmunoFormulation (IF) during the course of SARS-CoV-2

Screening criteria for an observational study 

All the patients attended the private clinic from March to May 2020. The data was collected in September 2020 for analysis. 40 patients were involved in the study who were tested positive in a diagnostic test for SARS-Co-V-2. 20 patients who received treatment with ImmunoFormulation (IF) were compared to another group of 20 patients who received standard care only. 

The screening criteria were as follows: 

Patients were 18 years of age or older  Patients have given written consent to participate in the study  The patients suffering from COVID19 symptoms from March to May 2020  Patients who were tested positive for the SARS-Co-V-2 diagnostic test  Patients with onset of COVID19 >5 days prior to the diagnosis of SARS-Co-V-2 

Results: A total of 40 patients participated in the study ( 20 in  ImmunoFormulation (IF) cohort study  / 20 on control cohort study). The patients were evaluated for efficacy of ImmunoFormulation (IF). The control cohort received standard care only and the  ImmunoFormulation (IF)cohort received standard care + ImmunoFormulation (IF). 

After comparison, It was observed in the  

ImmunoFormulation (IF) cohort observational study showed:

50% mild cases 

30 % moderate cases 

20% severe cases 

In the control cohort, an observational study showed: 

36.2% mild cases

26.3% moderate cases 

36.5% severe cases 

Throughout the observational study, 90% of patients recovered from the ImmunoFormulation (IF) cohort and 47.4% from the control cohort. The percentage of recovery in an observational study is better in the group treated with  ImmunoFormulation (IF). 

The conclusion from Observational study. 

In the treatment of COVID19, it is important to target the SARS-Co-V-2 to eliminate and improve the symptomatology by strengthening the natural defenses. Immune Formulation (IF) helped in abstaining fast recovery and better outcomes. A higher concentration of essential vitamins and minerals inhibited the replication of SARS-Co-V-2 avoiding the virus from entering the cell and multiply. This will help reduce the transmission of viruses from one person to another. 

Importance of  ImmunoFormulation (IF) and nutraceuticals

The study demonstrates that the consumption of vitamin supplements with a good amount of Vitamin D, Vitamin C, Vitamin B, Zinc, Selenium which has good antioxidant and antiinflammatory properties is good for the body to prevent the COVID19 and better recovery. These all vitamins will help contribute to reducing oxidative stress. This study promises the potential role of  ImmunoFormulation (IF) as adjuvant therapy in the COVID19 patients.  

Tags : #medicircle #myhealth #immunesystem #ImmunoFormulation #COVID19

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Serum Institute of India Partners with Oxford University to Develop Meningitis-B VaccineApril 18, 2024
Ethical Concerns Arise: Nestlé Accused of Adding Sugar and Honey to Infant Formula and Breakfast Cereals in Low-Income CountriesApril 18, 2024
Empowering India's Youth: IG Drones & AASSC Launch Drone Skill Program, to Upskill 10M YouthApril 17, 2024
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment TechnologyApril 17, 2024
Top 5 online learning platform for learnersApril 17, 2024
Broad-Spectrum RNA Vaccine Breakthrough for Enhanced Virus ProtectionApril 17, 2024
The Impact of Excessive Internet Usage on School Absence: Finnish Study Reveals Key FindingsApril 17, 2024
Uncovering Delhi's Illegal Fertility Centre Operations: Insights from Recent Child Trafficking CasesApril 17, 2024
CarDekho's CSR Arm Girnar Foundation Hosts Health Check-up Camps for Underprivileged Children in Jaipur and GurugramApril 16, 2024
Atal Incubation Centre – Centre for Cellular and Molecular Biology (AIC-CCMB) signs agreement for placement of equipment with Thermo Fisher Scientific to help advance innovation in India April 16, 2024
AVEKSHA, four-day care centres, for the kids of industrial workers inauguratedApril 16, 2024
Nearly a third of the constituencies have zero women candidates in Phase 1 and 2 of LS Elections; reveals The Quantum Hub’s Factsheet April 16, 2024
Emergency Healthcare Provider Medulance Secures $3 Million Series A Funding Led by Alkemi Growth CapitalApril 16, 2024
The Healing Power of Natural Diversity: How Nature Boosts Mental HealthApril 16, 2024
Unveiling Cellular Recycling: How Nutrient-Starved Cells Adapt to Stressful ConditionsApril 16, 2024
Advancing Cancer Care: AIIMS Bhopal’s Workshop on Biomarker Interpretation in Breast CancerApril 15, 2024
10 Powerful Benefits to Diversify Healthcare Advertising ChannelsApril 15, 2024
Understanding Hospital Sink Contamination: Challenges in Fighting Multidrug-Resistant BacteriaApril 15, 2024
Rajasthan’s Swine Flu Situation: Health Department Observes DeclineApril 15, 2024
Is Your Doctor’s Prescription Incomplete ? Insights from Recent ICMR Study Suggests So!April 13, 2024